Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
International Urology and Nephrology|September 26, 2019
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancerKenichiro Fukuoka, Jun Teishima, Hirotaka Nagamatsu, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2020
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsJun Teishima, Shogo Inoue, Tetsutaro Hayashi, et al.Molecular and Clinical Oncology|June 28, 2021
Erratum: Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapyJun Teishima, Daiki Murata, Shogo Inoue, et al.Current Urology|January 24, 2022
Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorJun Teishima, Daiki Murata, Shogo Inoue, et al.International Journal of Clinical Oncology|January 22, 2026
Real-world clinical utility and challenges of comprehensive genomic profiling for advanced solid tumors in a community health institutionMihoko Doi, Nobuhisa Ishikawa, Katsunori Shinozaki, et al.Journal of Endourology|August 10, 2012
Impact of laparoscopic experience on the proficiency gain of urologic surgeons in robot-assisted surgeryJun Teishima, Minoru Hattori, Shogo Inoue, et al.Oncology Letters|July 12, 2014
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapyJun Teishima, Kohei Kobatake, Tetsutaro Hayashi, et al.Urologic Oncology|October 28, 2025
Time-dependent changes in pathological risk factors of recurrence after renal cell carcinoma surgeryHiroyuki Shikuma, Yuki Kohada, Keisuke Goto, et al.Urologic Oncology|August 6, 2017
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorJun Teishima, Kohei Kobatake, Shunsuke Shinmei, et al.Urologic Oncology|July 19, 2022
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitorKazuma Yukihiro, Jun Teishima, Keisuke Goto, et al.Pageof 5